Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

RCN Welcomes EU-wide Agreement On Medical Sharps Injuries
Commenting on the announcement by European Federation of Public Service Unions (EPSU) and the European Hospital and Healthcare Employers Association (HOSPEEM) of an EU-wide agreement set to prevent 1 million medical sharps injuries per year, Dr Peter Carter, Chief Executive & General Secretary of the Royal College of Nursing (RCN), said:
generic viagra online
Sub-Optimal Treatment Threatening Survival Of HIV/AIDS Patients
Stagnation in HIV/AIDS funding and the high cost of new medicines are putting the lives of thousands of poor patients at risk, the international medical humanitarian organization Doctors Without Borders/Mç©decins Sans Frontiç¨res (MSF) warned today at the 2009 International AIDS Society conference in South Africa . Patients needing new drug regimens will return to AIDS "death row." While the lack of access to antiretroviral treatment for seven million people remains unaddressed, inadequate financing now further threatens treatment scale-up.
News of the day
Provectus Reports Encouraging Clinical Data At ASCO On Treatment Of Metastatic Melanoma With PV-10
Provectus Pharmaceuticals, Inc. (OTC Bulletin Board: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has announced interim data from the first 40 subjects in its Phase 2 clinical trial for the treatment of metastatic melanoma. PV-10 treatment was well tolerated and caused selective tumor destruction in the majority of subjects. Additional data on untreated tumors corroborated observations of a possible bystander effect seen during earlier Phase 1 testing. These data were presented today at the American Society of Clinical Oncology 2009 Annual Meeting, Abstract #9060, entitled "Chemoablation of melanoma with intralesional rose bengal (PV-10)," in the General Poster Session.
Diagnostics

The Journal "Foot & Ankle Specialist" Accepted In Medline

Foot & Ankle Specialist (FAS), published by SAGE, has been accepted for inclusion in MEDLINE, the premier bibliographic database of the U.S. National Library of Medicine (NLM), containing more than 16 million journal article citations. "FAS is privileged to be among the high-quality journals accepted into MEDLINE," said co-editor Gregory C. Berlet, MD. "Researchers and clinicians concerned with foot and ankle care will now be better able to access and disseminate the techniques and advancements published in the journal." Foot & Ankle Specialist is a peer-reviewed bimonthly journal offering clinical information for foot and ankle caregivers. Written and edited by orthopaedic surgeons and podiatrists, FAS offers the latest techniques and advancements in foot and ankle treatment through research reports and reviews, technical perspectives, case studies, and other evidence-based articles. FAS enables practitioners to address a broad range of disorders and provide their patients with the best current diagnosis and therapy. "SAGE is very pleased to see the important work published in FAS now included in this prestigious database," said Ron Epstein, SAGE Director, STM Journals. "It is a testament to the quality of the work and dedication of the editors Gregory C. Berlet and Babak Baravarian and the entire editorial team." Jim Gilden SAGE Publications


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009